Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability
<p>Abstract</p> <p>Background</p> <p>The recent H1N1 influenza pandemic illustrated the shortcomings of the vaccine manufacturing process. The A/California/07/2009 H1N1 pandemic influenza vaccine or A(H1N1)pdm09 was available late and in short supply as a result of dela...
Main Authors: | Feshchenko Elena, Rhodes David G, Felberbaum Rachael, McPherson Clifton, Rininger Joseph A, Post Penny, Cox Manon MJ |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | BMC Biotechnology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1472-6750/12/77 |
Similar Items
-
Risk Factors for Influenza A(H1N1)pdm09 among Students, Beijing, China
by: Yang Zheng, et al.
Published: (2013-02-01) -
The Effect of Mice Adaptation Process on the Pathogenicity of Influenza A/South Africa/3626/2013 (H1N1)pdm09 Model Strain
by: Mohammad Al Farroukh, et al.
Published: (2023-12-01) -
CHANGE OF PHENOTYPIC PROPERTIES OF ESCAPE MUTANTS AND READAPTANTS OF INFLUENZA VIRUS A (H1N1) PDM09 UNDER THE INFLUENCE OF SELECTED MUTATIONS IN THE MOLECULE OF HEMAGGLUTININ
by: T. A. Timofeeva, et al.
Published: (2019-04-01) -
Cloning, Expression, and Purification of the Recombinant Hemagglutinin of Human Influenza Virus H1N1 in the Eukaryotic Insect Cells Using Baculovirus Vector
by: Niloufar Rashedi, et al.
Published: (2020-07-01) -
Coinfection with influenza A(H1N1)pdm09 and dengue virus in fatal cases
by: Anne Carolinne Bezerra Perdigão, et al.
Published: (2016-01-01)